Arcus Biosciences Q3 EPS $(0.51) Down From $(0.25) YoY, Sales $1.75M Down From $4.291M YoY

Arcus Biosciences (NYSE:RCUS) reported quarterly losses of $(0.51) per share. This is a 104 percent decrease over losses of $(0.25) per share from the same period last year. The company reported $1.75 million in sales

Benzinga · 11/05/2019 21:49

Arcus Biosciences (NYSE:RCUS) reported quarterly losses of $(0.51) per share. This is a 104 percent decrease over losses of $(0.25) per share from the same period last year. The company reported $1.75 million in sales this quarter. This is a 59.22 percent decrease over sales of $4.291 million the same period last year.